🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in users administering substances of uncertain source.

Several experts said the popularity for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Service Response and Material Removal

According to TikTok, the service has taken down violative material and prohibited associated hashtags and search suggestions. The company said it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at home.

After minutes of entering one community, a vendor posted WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Product Details and Costs

Inside these groups, posts display black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially significant medical dangers”.